Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PEDICULICIDE MANUFACTURERS MUST APPLY INDIVIDUALLY FOR EXTENSIONS

This article was originally published in The Tan Sheet

Executive Summary

PEDICULICIDE MANUFACTURERS MUST APPLY INDIVIDUALLY FOR EXTENSIONS to the Dec. 14, 1994 effective date of the OTC final monograph as they phase out old labeling mandated by the Environmental Protection Agency and adopt the new FDA labeling, FDA advised the Nonprescription Drug Manufacturers Association in a June 1 letter. In response to NDMA's request for a one-and-a- half year delay in the effective date, FDA said it would not grant an extension "on a blanket basis for all products."
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS082942

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel